Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 2 OF 146 | DISPLAYING 16 - 30 OF 2181 RESULTS

    Calabrese D.R. et. al., Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex, https://doi.org/10.1038/s41467-018-06315-w, Nature Commun., Oct 12, 2018

    Angelova M. et. al., Evolution of Metastases in Space and Time under Immune Selection, https://doi.org/10.1016/j.cell.2018.09.018, Cell, Oct 11, 2018

    Mortison J.D. et. al., Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures, https://doi.org/10.1016/j.chembiol.2018.09.010, Cell Chemical Biol., Oct 11, 2018

    Aggarwal S.D. et. al., Function of BriC peptide in the pneumococcal competence and virulence portfolio, 10.1371/journal.ppat.1007328, PLoS Pathogens, Oct 11, 2018

    Zhang Y. et. al., A transportome-scale amiRNA-based screen identifies redundant roles of Arabidopsis ABCB6 and ABCB20 in auxin transport, https://doi.org/10.1038/s41467-018-06410-y, Nature Commun., Oct 11, 2018

    Hellbach N. et. al., Impaired myogenic development, differentiation and function in hESC-derived SMA myoblasts and myotubes, 10.1371/journal.pone.0205589, PLoS ONE, Oct 10, 2018

    Pillar N. et. al., Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness, https://doi.org/10.1038/s41419-018-1094-8, Cell Death & Disease, Oct 10, 2018

    Wenzl K. et. al., Loss of TNFAIP3 enhances MYD88L265P-driven signaling in non-Hodgkin lymphoma, https://doi.org/10.1038/s41408-018-0130-3, Blood Cancer, Oct 09, 2018

    Medler T.R. et. al., Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy, https://doi.org/10.1016/j.ccell.2018.09.003, Cancer Cell, Oct 08, 2018

    Tasaki S. et. al., The Molecular and Neuropathological Consequences of Genetic Risk for Alzheimer's Dementia, 10.3389/fnins.2018.00699, Front. Neurosci., Oct 08, 2018

    Kahn S.A. et. al., Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma, https://doi.org/10.1038/s41467-018-06564-9, Nature Commun., Oct 08, 2018

    Amaria R.N. et. al., Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma, https://doi.org/10.1038/s41591-018-0197-1, Nature Med., Oct 08, 2018

    Blabk C.U. et. al., Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma, https://doi.org/10.1038/s41591-018-0198-0, Nature Med., Oct 08, 2018

    House R. et. al., Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer, 10.1371/journal.pone.0205077, PLoS ONE, Oct 05, 2018

    Houot R. et. al., Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study, https://doi.org/10.1038/s41375-018-0282-y, Leukemia, Oct 05, 2018